256 related articles for article (PubMed ID: 10227815)
1. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.
Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K
Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human B cell activation by gold compounds.
Hirohata S
Clin Immunol Immunopathol; 1996 Nov; 81(2):175-81. PubMed ID: 8906749
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin.
Hashimoto K; Whitehurst CE; Lipsky PE
J Rheumatol; 1994 Jun; 21(6):1020-6. PubMed ID: 7932408
[TBL] [Abstract][Full Text] [Related]
4. Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
Parente JE; Walsh MP; Girard PR; Kuo JF; Ng DS; Wong K
Mol Pharmacol; 1989 Jan; 35(1):26-33. PubMed ID: 2536465
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of auranofin, gold sodium thiomalate, and penicillamine on resorption of cultured fetal rat long bones.
Vargas SJ; Jones TG; Hurley MM; Raisz LG
J Bone Miner Res; 1987 Jun; 2(3):183-9. PubMed ID: 3137774
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of two gold compounds, and D-penicillamine on the production of interferon gamma.
Harth M; Cousin K; McCain GA
Immunopharmacol Immunotoxicol; 1990; 12(1):39-60. PubMed ID: 2112569
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.
Hashimoto K; Whitehurst CE; Matsubara T; Hirohata K; Lipsky PE
J Clin Invest; 1992 Jun; 89(6):1839-48. PubMed ID: 1351061
[TBL] [Abstract][Full Text] [Related]
8. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
[TBL] [Abstract][Full Text] [Related]
9. T cell regulation of in vitro IgM-rheumatoid factor production by normal human B cells. Differential effects of stimulation with immobilized monoclonal antibodies to CD3 and Staphylococcus aureus.
Hirohata S; Inoue T; Miyamoto T
Arerugi; 1990 Feb; 39(2 Pt 1):82-9. PubMed ID: 2141251
[TBL] [Abstract][Full Text] [Related]
10. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
Zetterström CK; Jiang W; Wähämaa H; Ostberg T; Aveberger AC; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Erlandsson Harris H
J Leukoc Biol; 2008 Jan; 83(1):31-8. PubMed ID: 17913975
[TBL] [Abstract][Full Text] [Related]
11. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
12. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis.
Hassan J; Hanly J; Bresnihan B; Feighery C; Whelan CA
Clin Exp Immunol; 1986 Mar; 63(3):614-20. PubMed ID: 3086003
[TBL] [Abstract][Full Text] [Related]
13. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog.
Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG
J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.
Lipsky PE; Ziff M
J Clin Invest; 1977 Mar; 59(3):455-66. PubMed ID: 838859
[TBL] [Abstract][Full Text] [Related]
15. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
Walz DT; DiMartino MJ; Griswold DE
J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
[TBL] [Abstract][Full Text] [Related]
16. A mechanism of action of gold sodium thiomalate in diseases characterized by a proliferative synovitis: reversible changes in collagen production in cultured human synovial cells.
Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
J Pharmacol Exp Ther; 1981 Aug; 218(2):395-403. PubMed ID: 6788936
[TBL] [Abstract][Full Text] [Related]
17. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
Danis VA; Franic GM; Brooks PM
Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2-chlorodeoxyadenosine and gold sodium thiomalate on human bcl-2 gene expression.
Sfikakis PP; Dimopoulos MA; Souliotis VL; Charalambopoulos D; Mavrikakis M; Panayiotidis P
Immunopharmacol Immunotoxicol; 1998 Feb; 20(1):63-77. PubMed ID: 9543700
[TBL] [Abstract][Full Text] [Related]
19. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues.
Griem P; Takahashi K; Kalbacher H; Gleichmann E
J Immunol; 1995 Aug; 155(3):1575-87. PubMed ID: 7543525
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites.
Hashimoto K; Lipsky PE
J Rheumatol; 1993 Jun; 20(6):953-7. PubMed ID: 8350330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
